Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

P. D. Home

首页> 外文期刊>Diabetologia >Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

【24h】

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

机译：评论：Nauck MA，Duran S，Kim D等人（2007年）对磺脲类和二甲双胍亚最佳控制的2型糖尿病患者每天两次艾塞那肽和双相门冬胰岛素的比较：一项非劣效性研究。糖尿病50：259–267

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Diabetologia》 |2007年第7期|1561-1562|共2页
作者
P. D. Home;
展开▼
作者单位

SCMS-Diabetes The Medical School Newcastle University Newcastle upon Tyne NE2 4HH UK;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267 [J] . M. A. Nauck, M. Trautman, R. Brodows, Diabetologia . 2007,第7期

机译：对评论的回应：Nauck MA，Duran S，Kim D等人（2007年）对磺脲类和二甲双胍亚最佳控制的2型糖尿病患者每日两次艾塞那肽和双相门冬胰岛素的比较：一项非劣效性研究。糖尿病50：259–267
2. A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study [J] . M. A. Nauck, S. Duran, D. Kim, Diabetologia . 2007,第2期

机译：磺脲类和二甲双胍亚最佳控制的2型糖尿病患者每日两次艾塞那肽和双相门冬胰岛素的比较：一项非劣效性研究
3. Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride. [J] . stigma of screening suffering from screening and impact of screening on patients independence. The internal consistency of each of the above subscales was good with Cronbachs alpha ranging from 0.58 0.85. CONCLUSION: The PRISM PC questionnaire captu, Attitude to Health, Cross Sectional Studies Diabetes research and clinical practice . 2009,第1期

机译：磺脲类药物对转换为胰岛素治疗的影响（每日两次双天冬胰岛素30）：比较2型糖尿病患者在亚最大格列美脲控制不佳的情况下每天两次两次天冬胰岛素30含或不含格列美脲的比较。
4. Incidence of hypoglycemia and associated costs in Type 1and Type 2 diabetes patients treated with insulin analogs vs. human insulin: A retrospective cohort study. [D] . Shah, Hiren P. 2014

机译：使用胰岛素类似物与人胰岛素治疗的1型和2型糖尿病患者的低血糖发生率和相关费用：一项回顾性队列研究。
5. Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter Open-Label Randomized Trial [O] . Li Wang, Xiangyang Liu, Wenjuan Yang, 2020

机译：用二甲双胍单药治疗的2型糖尿病患者艾塞那肽和双相胰岛素Aspart 30在中国参与者中的血糖变异性比较：多中心开放标签随机试验
6. Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267 [O] . M. A. Nauck, M. Trautman, R. Brodows, 2007

机译：对评论的回应：Nauck MA，Duran S，Kim D等人（2007）对2型糖尿病患者的两次exenatide和双相胰岛素Aspart进行比较，患有磺酰脲和二甲双胍的2型糖尿病：一种非劣级研究。糖尿病症50：259-267

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

著录项

相似文献

相关主题

期刊订阅